183 related articles for article (PubMed ID: 20697857)
1. CT assessment of breast cancer for pathological involvement of four or more axillary nodes.
Ogino I; Tayama Y; Arai M; Inoue T; Shimizu D; Ishikawa T
Breast Cancer; 2012 Apr; 19(2):125-30. PubMed ID: 20697857
[TBL] [Abstract][Full Text] [Related]
2. Complete axillary lymph node dissection for stage I-II carcinoma of the breast.
Danforth DN; Findlay PA; McDonald HD; Lippman ME; Reichert CM; d'Angelo T; Gorrell CR; Gerber NL; Lichter AS; Rosenberg SA
J Clin Oncol; 1986 May; 4(5):655-62. PubMed ID: 3701387
[TBL] [Abstract][Full Text] [Related]
3. Thin-section CT evaluation and pathologic correlation of therapeutic effect of neoadjuvant chemotherapy for axillary lymph nodes of clinically node-positive breast cancer patients.
Ogawa Y; Nishioka A; Nishigawa T; Kubota K; Kariya S; Yoshida S; Tanaka Y; Moriki T; Tochika N
Oncol Rep; 2003; 10(4):985-9. PubMed ID: 12792757
[TBL] [Abstract][Full Text] [Related]
4. Level III axillary lymph nodes involvement in node positive breast cancer received neoadjuvant chemotherapy.
Fan Z; Li J; Wang T; Xie Y; Fan T; Lin B; Ouyang T
Breast; 2013 Dec; 22(6):1161-5. PubMed ID: 24080493
[TBL] [Abstract][Full Text] [Related]
5. Early assessment of axillary response with ¹⁸F-FDG PET/CT during neoadjuvant chemotherapy in stage II-III breast cancer: implications for surgical management of the axilla.
Koolen BB; Valdés Olmos RA; Wesseling J; Vogel WV; Vincent AD; Gilhuijs KG; Rodenhuis S; Rutgers EJ; Vrancken Peeters MJ
Ann Surg Oncol; 2013 Jul; 20(7):2227-35. PubMed ID: 23456316
[TBL] [Abstract][Full Text] [Related]
6. The surgeon as the most important factor in lymph node harvest during axillary clearance.
Naumann DN; Sintler M
Anticancer Res; 2013 Sep; 33(9):3935-9. PubMed ID: 24023331
[TBL] [Abstract][Full Text] [Related]
7. [The extent of radical axillary lymph node excision].
Müller A; Mattfeld T; Engel K; Schmidt W; Bastert G
Geburtshilfe Frauenheilkd; 1990 Jul; 50(7):524-7. PubMed ID: 2391018
[TBL] [Abstract][Full Text] [Related]
8. [Management of the axilla in breast cancer: evidences and unresolved issues].
Fodor J; Polgár C; Péley G; Németh G
Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
[TBL] [Abstract][Full Text] [Related]
9. Distribution of axillary lymph node metastases in different levels and groups in breast cancer, a pathological study.
Khafagy M; Mostafa A; Fakhr I
J Egypt Natl Canc Inst; 2011 Mar; 23(1):25-30. PubMed ID: 22099933
[TBL] [Abstract][Full Text] [Related]
10. A pilot study to assess the utility of SPECT/CT-based lymph node imaging to localize lymph nodes that drain the arm in patients undergoing treatment for breast cancer.
Cheville AL; Das I; Srinivas S; Schuerman J; Velders L; Solin LJ; Basu S; Alavi A
Breast Cancer Res Treat; 2009 Aug; 116(3):531-8. PubMed ID: 19152027
[TBL] [Abstract][Full Text] [Related]
11. Comparison between single photon emission computed tomography with computed tomography and planar scintigraphy in sentinel node biopsy in breast cancer patients.
Koizumi M; Koyama M
Ann Nucl Med; 2019 Mar; 33(3):160-168. PubMed ID: 30456550
[TBL] [Abstract][Full Text] [Related]
12. Factors affecting lymph node yield in patients undergoing axillary node dissection for primary breast cancer: a single-institution review.
Lee MC; Plews R; Rawal B; Kiluk JV; Loftus L; Laronga C
Ann Surg Oncol; 2012 Jun; 19(6):1818-24. PubMed ID: 22203185
[TBL] [Abstract][Full Text] [Related]
13. Diffusion-weighted MR imaging increases diagnostic accuracy of breast MR imaging for predicting axillary metastases in breast cancer patients.
Guvenc I; Whitman GJ; Liu P; Yalniz C; Ma J; Dogan BE
Breast J; 2019 Jan; 25(1):47-55. PubMed ID: 30444286
[TBL] [Abstract][Full Text] [Related]
14. Intraoperative sentinel node biopsy by one-step nucleic acid amplification (OSNA) avoids axillary lymphadenectomy in women with breast cancer treated with neoadjuvant chemotherapy.
Navarro-Cecilia J; Dueñas-Rodríguez B; Luque-López C; Ramírez-Expósito MJ; Martínez-Ferrol J; Ruíz-Mateas A; Ureña C; Carrera-González MP; Mayas MD; Martínez-Martos JM
Eur J Surg Oncol; 2013 Aug; 39(8):873-9. PubMed ID: 23711734
[TBL] [Abstract][Full Text] [Related]
15. The role of ultrasonography and FDG-PET in axillary lymph node staging of breast cancer.
Ahn JH; Son EJ; Kim JA; Youk JH; Kim EK; Kwak JY; Ryu YH; Jeong J
Acta Radiol; 2010 Oct; 51(8):859-65. PubMed ID: 20670083
[TBL] [Abstract][Full Text] [Related]
16. Axillary lymph node dissection in node-positive breast cancer: are ten nodes adequate and when is enough, enough?
Rosenberger LH; Ren Y; Thomas SM; Greenup RA; Fayanju OM; Hwang ES; Plichta JK
Breast Cancer Res Treat; 2020 Feb; 179(3):661-670. PubMed ID: 31741179
[TBL] [Abstract][Full Text] [Related]
17. The relation of visualization of internal mammary lymph nodes on lymphoscintigraphy to axillary lymph node metastases in breast cancer.
Kim H; Shin MJ; Kim SJ; Kim IJ; Park I
Lymphat Res Biol; 2014 Dec; 12(4):295-300. PubMed ID: 25144255
[TBL] [Abstract][Full Text] [Related]
18. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.
Veronesi U; Paganelli G; Galimberti V; Viale G; Zurrida S; Bedoni M; Costa A; de Cicco C; Geraghty JG; Luini A; Sacchini V; Veronesi P
Lancet; 1997 Jun; 349(9069):1864-7. PubMed ID: 9217757
[TBL] [Abstract][Full Text] [Related]
19. Diffusion weighted images of metastatic as compared with nonmetastatic axillary lymph nodes in patients with newly diagnosed breast cancer.
Yamaguchi K; Schacht D; Nakazono T; Irie H; Abe H
J Magn Reson Imaging; 2015 Sep; 42(3):771-8. PubMed ID: 25556886
[TBL] [Abstract][Full Text] [Related]
20. Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure.
Donker M; Straver ME; Wesseling J; Loo CE; Schot M; Drukker CA; van Tinteren H; Sonke GS; Rutgers EJ; Vrancken Peeters MJ
Ann Surg; 2015 Feb; 261(2):378-82. PubMed ID: 24743607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
